The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $35.36

Today's change+0.48 +1.38%
Updated June 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $35.36

Today's change+0.48 +1.38%
Updated June 22 4:02 PM EDT. Delayed by at least 15 minutes.

AstraZeneca PLC Hits New 52-week High

AstraZeneca PLC closed up Thursday by (U.S.)$0.48 or 1.38% to (U.S.)$35.36 and setting a new 52-week high. Over the last five days, shares have gained 3.66% and 29.43% year to date. Shares have outperformed the S&P 500 by 6.47% during the last year.

Key company metrics

  • Open(U.S.) $35.00
  • Previous close(U.S.) $34.88
  • High(U.S.) $35.60
  • Low(U.S.) $34.98
  • Bid / Ask(U.S.) $34.00 / (U.S.) $35.80
  • YTD % change+29.43%
  • Volume4,015,315
  • Average volume (10-day)3,817,677
  • Average volume (1-month)4,398,590
  • Average volume (3-month)4,261,480
  • 52-week range(U.S.) $25.55 to (U.S.) $35.60
  • Beta0.74
  • Trailing P/E26.41×
  • P/E 1 year forward18.79×
  • Forward PEG2.57×
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield3.96%
  • Trailing EPS(U.S.) $1.34
Updated June 22 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.47%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue5,4055,5855,6995,603
Total other revenue--------
Total revenue5,4055,5855,6995,603
Gross profit4,5494,4684,8584,560
Total cost of revenue8561,1178411,043
Total operating expense4,4883,0524,6715,300
Selling / general / administrative1,9292,1331,9682,191
Research & development1,3381,4811,3371,384
Depreciation / amortization284298297309
Interest expense (income), net operating--------
Unusual expense (income)414-835335765
Other operating expenses, total-333-1,142-107-392
Operating income9172,5331,028303
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5822,183676-30
Income after tax5121,817995-31
Income tax, total70366-3191
Net income5371,8421,014-3
Total adjustments to net income--------
Net income before extra. items5371,8421,014-3
Minority interest25251928
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5371,8421,014-3
Inc. avail. to common incl. extra. items5371,8421,014-3
Diluted net income5371,8421,014-3
Dilution adjustment--00--
Diluted weighted average shares1,2661,2661,2661,265
Diluted EPS excluding extraordinary itemsvalue per share0.421.450.800.00
Dividends per sharevalue per share0.001.850.000.90
Diluted normalized EPSvalue per share0.711.151.070.59